These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 35275164)

  • 1. Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder.
    Garrison-Desany HM; Hong X; Maher BS; Beaty TH; Wang G; Pearson C; Liang L; Wang X; Ladd-Acosta C
    JAMA Netw Open; 2022 Mar; 5(3):e221957. PubMed ID: 35275164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children.
    Trønnes JN; Lupattelli A; Handal M; Skurtveit S; Ystrom E; Nordeng H
    JAMA Netw Open; 2021 Sep; 4(9):e2124324. PubMed ID: 34524436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Maternal Exposure to Magnetic Field Nonionizing Radiation During Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in Offspring in a Longitudinal Birth Cohort.
    Li DK; Chen H; Ferber JR; Hirst AK; Odouli R
    JAMA Netw Open; 2020 Mar; 3(3):e201417. PubMed ID: 32207831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population.
    Azuine RE; Ji Y; Chang HY; Kim Y; Ji H; DiBari J; Hong X; Wang G; Singh GK; Pearson C; Zuckerman B; Surkan PJ; Wang X
    JAMA Netw Open; 2019 Jun; 2(6):e196405. PubMed ID: 31251378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Cannabis Polysubstance Use During Early Pregnancy Among Patients in a Large Health Care System in Northern California.
    Young-Wolff KC; Sarovar V; Tucker LY; Ansley D; Goler N; Conway A; Ettenger A; Foti TR; Brown QL; Kurtzman ET; Adams SR; Alexeeff SE
    JAMA Netw Open; 2022 Jun; 5(6):e2215418. PubMed ID: 35666502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring.
    Harris GM; Wood M; Ystrom E; Nordeng H
    JAMA Netw Open; 2022 Jun; 5(6):e2215333. PubMed ID: 35657626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Perinatal and Childhood Ischemic Stroke With Attention-Deficit/Hyperactivity Disorder.
    Bolk J; Simatou E; Söderling J; Thorell LB; Persson M; Sundelin H
    JAMA Netw Open; 2022 Apr; 5(4):e228884. PubMed ID: 35471571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How does maternal alcohol consumption during pregnancy affect the development of attention deficit/hyperactivity syndrome in the child].
    Burger PH; Goecke TW; Fasching PA; Moll G; Heinrich H; Beckmann MW; Kornhuber J
    Fortschr Neurol Psychiatr; 2011 Sep; 79(9):500-6. PubMed ID: 21739408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Childhood.
    Ji Y; Azuine RE; Zhang Y; Hou W; Hong X; Wang G; Riley A; Pearson C; Zuckerman B; Wang X
    JAMA Psychiatry; 2020 Feb; 77(2):180-189. PubMed ID: 31664451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Maternal Autoimmune Disease With Attention-Deficit/Hyperactivity Disorder in Children.
    Nielsen TC; Nassar N; Shand AW; Jones H; Guastella AJ; Dale RC; Lain SJ
    JAMA Pediatr; 2021 Mar; 175(3):e205487. PubMed ID: 33464287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
    Wei YJ; Zhu Y; Liu W; Bussing R; Winterstein AG
    JAMA Netw Open; 2018 Aug; 1(4):e181152. PubMed ID: 30646105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.
    Chung W; Jiang SF; Paksarian D; Nikolaidis A; Castellanos FX; Merikangas KR; Milham MP
    JAMA Netw Open; 2019 Nov; 2(11):e1914344. PubMed ID: 31675080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.
    Christensen J; Pedersen L; Sun Y; Dreier JW; Brikell I; Dalsgaard S
    JAMA Netw Open; 2019 Jan; 2(1):e186606. PubMed ID: 30646190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood.
    Sundbakk LM; Gran JM; Wood ME; Handal M; Skurtveit S; Nordeng H
    JAMA Netw Open; 2022 Dec; 5(12):e2246889. PubMed ID: 36520439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort.
    Shi Y; Hunter Guevara LR; Dykhoff HJ; Sangaralingham LR; Phelan S; Zaccariello MJ; Warner DO
    JAMA Netw Open; 2021 Mar; 4(3):e210321. PubMed ID: 33646315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association of Prenatal Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccination With Attention-Deficit/Hyperactivity Disorder.
    Becerra-Culqui TA; Getahun D; Chiu V; Sy LS; Tseng HF
    Am J Epidemiol; 2020 Oct; 189(10):1163-1172. PubMed ID: 32378703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal smoking, alcohol and caffeine exposure and maternal-reported attention deficit hyperactivity disorder symptoms in childhood: triangulation of evidence using negative control and polygenic risk score analyses.
    Haan E; Sallis HM; Zuccolo L; Labrecque J; Ystrom E; Reichborn-Kjennerud T; Andreassen O; Havdahl A; Munafò MR
    Addiction; 2022 May; 117(5):1458-1471. PubMed ID: 34791750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Consequences of tobacco, cocaine and cannabis consumption during pregnancy on the pregnancy itself, on the newborn and on child development: A review].
    Lamy S; Laqueille X; Thibaut F
    Encephale; 2015 Jun; 41 Suppl 1():S13-20. PubMed ID: 25439854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
    Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
    JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana, Opioid, and Alcohol Use Among Pregnant and Postpartum Individuals Living With HIV in the US.
    Yee LM; Kacanek D; Brightwell C; Haddad LB; Jao J; Powis KM; Yao TJ; Barr E; Broadwell C; Siminski S; Seage GR; Chadwick EG;
    JAMA Netw Open; 2021 Dec; 4(12):e2137162. PubMed ID: 34860242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.